KOR

e-Article

Publication date
-
(ex : 2010-2015)
'e-Article' searched 392results | List 1~10
Academic Journal
Talvard-Balland N; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Braun LM; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Dixon KO; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Mass General Hospital and Harvard Medical School, Boston, United States of America.; Zwick M; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Engel H; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Hartmann A; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Duquesne S; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Andrieux G; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Freiburg, Germany.; Rindlisbacher LS; Institute of Experimental Immunology, University of Zurich, Zürich, Switzerland.; Acerbis A; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Ehmann J; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Köllerer C; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Ansuinelli M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Rettig A; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Moschallski K; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Apostolova P; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Brummer T; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Illert AL; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schramm MA; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Freiburg, Germany.; Cheng Y; Institute of Genetic Epidemiology, Medical Center - University of Freiburg, Freiburg, Germany.; Köttgen A; Institute of Genetic Epidemiology, Medical Center - University of Freiburg, Freiburg, Germany.; Duyster J; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Menssen HD; BioMedical Research, Novartis Institutes for BioMedical Research Inc., Basel, Switzerland.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Blazar BR; Department of Pediatrics, Division of Blood & Marrow Transplant & Cellular, University of Minnesota, Minneapolis, United States of America.; Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Freiburg, Germany.; Schmitt Graeff A; Department of General Pathology, Institute of Pathology, University of Freiburg, Freiburg, Germany.; Sariipek N; Division of Hematology, Brigham and Women's Hospital, Boston, United States of America.; van Galen P; Division of Hematology, Brigham and Women's Hospital, Boston, United States of America.; Buescher JM; Max-Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.; Cabezas-Wallscheid N; Max-Planck-Institute of Immunobiology and Epigenetics, Freiburg, Germany.; Pahl HL; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Pearce EL; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, United States of America.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.; Vago L; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milano, Italy.; Becher B; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Köhler N; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Wertheimer T; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.; Kuchroo VK; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Mass General Hospital and Harvard Medical School, Boston, United States of America.; Zeiser R; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.
Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Academic Journal
Levis MJ; Johns Hopkins University, Baltimore, MD.; Hamadani M; CIBMTR/Medical College of Wisconsin, Milwaukee, WI.; Logan B; CIBMTR/Medical College of Wisconsin, Milwaukee, WI.; Jones RJ; Johns Hopkins University, Baltimore, MD.; Singh AK; University of Kansas, Kansas City, KS.; Litzow M; Mayo Clinic, Rochester, MN.; Wingard JR; University of Florida, Gainesville, FL.; Papadopoulos EB; Memorial Sloan Kettering Cancer Center, New York, NY.; Perl AE; University of Pennsylvania, Philadelphia, PA.; Soiffer RJ; Dana-Farber Cancer Institute, Boston, MA.; Ustun C; Rush University Medical Center, Chicago, IL.; Ueda Oshima M; Fred Hutchinson Cancer Center, Seattle, WA.; Uy GL; Washington University, St Louis, MO.; Waller EK; Emory University, Atlanta, GA.; Vasu S; Ohio State University, Columbus, OH.; Solh M; Northside Hospital Cancer Institute, Atlanta, GA.; Mishra A; Moffitt Cancer Center, Tampa, FL.; Muffly L; Stanford University, Palo Alto, CA.; Kim HJ; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Mikesch JH; University of Muenster, Münster, Germany.; Najima Y; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.; Onozawa M; Hokkaido University Hospital, Sapporo, Japan.; Thomson K; University College Hospital, London, United Kingdom.; Nagler A; Chaim Sheba Medical Center, Tel Hashomer, Israel.; Wei AH; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Walter and Eliza Hill Institute of Medical Research and University of Melbourne, Melbourne, Australia.; Marcucci G; Beckman Research Institute of City of Hope, Duarte, CA.; Geller NL; National Heart, Lung and Blood Institute, Bethesda, MD.; Hasabou N; Astellas Pharma Inc, Northbrook, IL.; Delgado D; Astellas Pharma Inc, Northbrook, IL.; Rosales M; Astellas Pharma Inc, Northbrook, IL.; Hill J; Astellas Pharma Inc, Northbrook, IL.; Gill SC; Astellas Pharma Inc, Northbrook, IL.; Nuthethi R; Astellas Pharma Inc, Northbrook, IL.; King D; The Emmes Company, Rockville, MD.; Wittsack H; The Emmes Company, Rockville, MD.; Mendizabal A; The Emmes Company, Rockville, MD.; Devine SM; National Marrow Donor Program, Minneapolis, MN.; Horowitz MM; CIBMTR/Medical College of Wisconsin, Milwaukee, WI.; Chen YB; Massachusetts General Hospital, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Shapiro RM; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Kim HT; Dana-Farber Cancer Inst., Boston, Massachusetts, United States.; Dulery R; Sorbonne University, Saint-Antoine Hospital, Assitance Publique - Hôpitaux de Paris, INSERM UMRs 938, Paris, France.; Liney D; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Garrity HM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States.; Panaro KM; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Au C; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Gervais C; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Little JS; Brigham and Women's Hospital, Boston, Massachusetts, United States.; Ho VT; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Cutler CS; Dana Farber Cancer Institute, Boston, Massachusetts, United States.; Koreth J; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Gooptu M; Dana- Farber Cancer Institute, Boston, Massachusetts, United States.; Antin JH; Dana-Farber, Boston, Massachusetts, United States.; Kelkar AH; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Romee R; Dana Farber / Harvard Medical School, Boston, Massachusetts, United States.; Wu CJ; Dana-Farber Cancer Institute; Harvard Medical School, Boston, Massachusetts, United States.; Ritz J; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Soiffer RJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States.; Nikiforow S; Dana-Farber Cancer Institute, Boston.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, Massachusetts. Electronic address: htkimc@jimmy.harvard.edu.; Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Cutler C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Shapiro RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Gooptu M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Romee R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Academic Journal
Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Murdock HM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ansuinelli M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.; Brock J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cutler CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Gooptu M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Romee R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Shapiro R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bat-Erdene D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Contreras ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Fell G; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Academic Journal
Kim H; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Ali R; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Short S; Larner College of Medicine, University of Vermont, Burlington, VT, USA.; Kaunfer S; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Krishnamurthy S; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Durai L; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Yilmam O; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Shenoy T; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Monson AE; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Thomas C; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Park I; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Martini D; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Newcomb R; Division of Hematology & Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA, USA.; Shapiro RM; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Soiffer RJ; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA, USA.; Baron RM; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Gupta S; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Adult Survivorship Program, Dana-Farber Cancer Institute, Boston, MA, USA.; Sise ME; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Leaf DE; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA. DELEAF@bwh.harvard.edu.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Academic Journal
Little JS; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: jlittle@bwh.harvard.edu.; Duléry R; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts; Sorbonne University, Department of Clinical Hematology and Cellular Therapy, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Inserm UMRs 938, Centre de recherche Saint-Antoine, Paris, France.; Shapiro RM; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Aleissa MM; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.; Prockop SE; Harvard Medical School, Boston, Massachusetts; Hematopoietic Stem Cell Transplant Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.; Koreth J; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ritz J; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Antin JH; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cutler C; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Nikiforow S; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Romee R; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Issa NC; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ho VT; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Soiffer RJ; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gooptu M; Harvard Medical School, Boston, Massachusetts; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Academic Journal
Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, Charitéplatz 1, 10117, Berlin, Germany.; Borji M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Nagler A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Lyu H; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Lu WS; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Cieri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Maurer K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Al'Khafaji AM; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Garimella KV; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA. catherine_wu@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. catherine_wu@dfci.harvard.edu.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Mouhieddine TH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Nzerem C; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Redd R; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dunford A; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Leventhal M; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Sklavenitis-Pistofidis R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Tahri S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Hematology, Erasmus MC Cancer Centre, Rotterdam, the Netherlands.; El-Khoury H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Steensma DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Keats JJ; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, Arizona.; Mehr S; Multiple Myeloma Research Foundation, Norwalk, Connecticut.; Auclair D; Multiple Myeloma Research Foundation, Norwalk, Connecticut.; Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Sperling AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts.; Stewart C; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Getz G; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE
Refining the search results
Facets
[AR] Soiffer RJ
Publication year
-
Database provider
Title
Publisher
자료유형(Source Type)
Subject
Language